Quest Diagnostics (DGX) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Quest Diagnostics (DGX) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.62 Bn | 208.56 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 139.22 Bn | 134.87 Bn | 3.61 Bn | -7.69% |
| 3 | Idexx Laboratories | 46.07 Bn | 45.88 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.35 Bn | 37.54 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 38.18 Bn | 36.10 Bn | 1.44 Bn | -6.41% |
| 6 | Natera | 37.68 Bn | 36.58 Bn | 696.04 Mn | 14.66% |
| 7 | Illumina | 28.60 Bn | 27.43 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.37 Bn | 28.32 Bn | 650.22 Mn | 2.87% |
| 9 | Quest Diagnostics | 26.30 Bn | 25.67 Bn | 1.03 Bn | 10.22% |
| 10 | Labcorp Holdings | 25.82 Bn | 24.84 Bn | 1.01 Bn | 284.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.22% |
| Mar 31, 2026 | 7.04% |
| Dec 31, 2025 | 30.13% |
| Sep 30, 2025 | -2.40% |
| Jun 30, 2025 | 5.27% |
| Mar 31, 2025 | -14.07% |
| Dec 31, 2024 | -15.87% |
| Sep 30, 2024 | -22.75% |
| Jun 30, 2024 | -31.96% |
| Mar 31, 2024 | -24.94% |
| Jun 30, 2022 | 130.84% |
| Dec 31, 2017 | 271.81% |
| Dec 31, 2014 | -1.79% |
| Sep 30, 2013 | 96.23% |
| Jun 30, 2013 | 270.53% |
| Mar 31, 2013 | 628.49% |
| Dec 31, 2012 | -653.95% |
| Sep 30, 2012 | 109.60% |
| Jun 30, 2012 | 183.26% |
| Mar 31, 2012 | 55.99% |